2021
2020
2019
2018
2017
2016
2015
1
2
3
→
»
Aytu BioPharma Adds Late-Stage Pediatric Onset Rare Disease Asset to Development Pipeline from Rumpus Therapeutics
Apr 12, 2021
Aytu BioPharma Strengthens Leadership Team with Appointment of Richard Eisenstadt as Chief Financial Officer
Apr 5, 2021
Aytu BioPharma Divests U.S. Rights to Natesto(R) to Acerus Pharma
Apr 1, 2021
Aytu BioScience Announces Close of Merger with Neos Therapeutics
Mar 22, 2021
Aytu BioScience Announces Positive Clinical Results from Healight(TM) Pilot Study in SARS-CoV-2 Patients
Mar 8, 2021
Aytu BioScience to Present at Upcoming March Investor Conferences
Feb 24, 2021